With the approval of the preliminary design (PD), an important milestone has been reached in the design process for the Aleida Nijland building. This means that the key functional and spatial decisions have now been finalised. The future users of the building – LUCL, part of LUCAS, lab users, LAK, ATC,…

Students from the Royal Academy of Art The Hague (KABK) designed the 450 lustrum logo.

Sometimes an idea seems so logical and elegant at first glance, that you later wonder why no one thought of it before. Two researchers from LACDR have teamed up to develop a completely synthetic alternative to antibodies—one that mimics their size, shape and function, but which is cheaper, more stable,…

Immunologist Leender Trouw specialises in the complement system, which is part of the immune system. In some diseases drugs help activate or inhibit this system. This is best done ‘in the right place at the right time’ − the title of his inaugural lecture.

The design for the METIS instrument for the Extremely Large Telescope (ELT) is final. The European Southern Observatory (ESO) has given the green light for production of all parts of the instrument. It is the first ELT instrument, designed and to be built under Dutch leadership, to formally pass the…

Future users of the Aleida Nijland building were recently the first to have the opportunity to admire the design plan for the new building. During a user meeting, architectural firm De Zwarte Hond presented the design, and future users of the building were able to share their wishes and ideas for further…

The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.

Learn to program, gain knowledge of AI methods, or use it in a research project at the LACDR. With the introduction of the innovative digital learning environment ‘Digital Labcoat’, Biopharmaceutical Sciences bachelor students can further develop their computational skills.

The future does not yet exist, but many people think about it daily. The course Designing Your Future, part of the Honours Programme at the Faculty of Governance and Global Affairs and taught by Bram Hoonhout‘Being a mentor during HOP week is something I can recommend to everyone’

Leiden researchers, led by Sebastian Pomplun developed a new method to screen hundreds of thousands of molecules for drug discovery, using mass spectrometry instead of DNA tags. ‘We wanted to make drug discovery faster and more accessible.’

Not experiments and lab coats, but computers and artificial intelligence: this year's Nobel Prize in Chemistry went to the inventors of the groundbreaking AI model, AlphaFold. This programme accurately predicts protein structures based on their genetic code—a crucial step in understanding biological…

Four university medical centres, including the LUMC, are joining forces to increase pandemic preparedness in the Netherlands.

'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…

Sharing knowledge based on research within organisations presents a challenging task. How can this be done effectively? What steps should be taken to ensure that knowledge obtained from research is shared and applied in the organisation's daily practice? On 8 May, the Leiden Leadership Centre (LLC)…

Getting motivation, courage and tools to find a job that will help you tackle the climate crisis: it is at the heart of the course ‘Designing Your Career as a Climate Changemaker’. With their final presentations, the students conclude this climate-specific skills module within the Designing Your Life…

Organisation

On 6 October 2021, Simone van der Hof gave a lecture on age verification and age appropriate design.

Workshop

Today, anyone wanting a new look for their living room watches a home decorating programme or buys an interior design magazine. In the eighteenth century, people went to an upholstry specialist, who would provide you with new wall coverings, curtains and much-needed accessories. PhD candidate Aagje…

How do we deal with large sources of greenhouse gases? Do schools provide a socially-inclusive environment for all children? And how can we protect Earth’s nature? These questions have two things in common: they are complex global challenges, and data can help answer them. Mitra Baratchi is computer…

Two consortia led by Leiden researchers have been awarded over one million euros by the Dutch Research Council and the Ministry of Health, Welfare and Sport to find solutions to antimicrobial resistance.

A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.

How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…

Scientific Director of the Leiden Academic Centre for Drug Research (LACDR) Hubertus Irth: ‘We test substances and look for new concepts for treating disease.’

The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a minimal dose. What’s more, the bacterium is far less likely to return, a major issue with existing antibiotics. The research was published in Nature Communications.

A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.